Details of the Drug

General Information of Drug (ID: DMMEPKR)

Drug Name

PEG-Interferon lambda (IL-29)

Indication

Disease Entry	ICD 11	Status	REF
Virus infection	1A24-1D9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease

Virus infection

ICD Disease Classification

1A24-1D9Z

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Interleukin-29 (IL29)	DTT	IFNL1	4.97E-01	-0.01	-0.02

Molecular Expression Atlas (MEA)

Jump to Detail Molecular Expression Atlas of This Drug

References

1	ClinicalTrials.gov (NCT00565539) Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection. U.S. National Institutes of Health.
2	Preclinical and clinical development of pegylated interferon-lambda 1 in chronic hepatitis C. J Interferon Cytokine Res. 2010 Aug;30(8):591-5.